| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/06/2002 | US6429356 Methods for producing carotenoid compounds, and specialty oils in plant seeds |
| 08/06/2002 | US6429355 Hepatitis C animal model |
| 08/06/2002 | US6429353 Endometriosis mouse model |
| 08/06/2002 | US6429308 Antisense oligonucleotide hybridizes with nucleic acid encoding cxcr4 protein to inhibit gene expression |
| 08/06/2002 | US6429307 Plant with dehydration stress inducible promoter; screening genomic dna library using plaque hybridization |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429302 Polynucleotides related to pancreatic disease |
| 08/06/2002 | US6429301 Polypeptide engineered mrna conjugates; libraries |
| 08/06/2002 | US6429300 Peptide acceptor ligation methods |
| 08/06/2002 | US6429299 Expression vectors for transgenic plants |
| 08/06/2002 | US6429298 Assays for identifying functional alterations in the p53 tumor suppressor |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429292 Glucuronide repressors and uses thereof |
| 08/06/2002 | US6429291 Hyaluronan receptor protein |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429186 Ligand antagonists for treatment of breast cancer |
| 08/06/2002 | US6429027 Composite arrays utilizing microspheres |
| 08/06/2002 | US6429014 Monoterpene synthases from grand fir (Abies grandis) |
| 08/06/2002 | US6429011 Neuronal apoptosis inhibitor protein gene sequence and mutations causative of spinal muscular atrophy |
| 08/06/2002 | US6429010 Treating schizophrenia |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6429007 Automated instrument for performing nucleic acid amplification reactions including a temperature control system which maintains two different temperatures in two reaction chambers |
| 08/06/2002 | US6429006 Use of recombinant yeasts expressing the lactate dehydrogenase gene so as to shift the glycolytic flux towards the production of lactic acid for greater yields |
| 08/06/2002 | US6429004 Transforming or transfecting a cell with a vector containing a polynucleotide which encodes a polypeptide having amidase activity useful for the production of optically active compounds |
| 08/06/2002 | US6429003 Genes encoding denitrification enzymes |
| 08/06/2002 | US6429001 Recombinant AAV packaging systems |
| 08/06/2002 | US6428997 Aminopeptidase derived from Bacillus licheniformis and process for preparation of natural type proteins |
| 08/06/2002 | US6428993 Phytophthora or pythium; for producing a gel or protein gelation composition; novel amino acid sequence |
| 08/06/2002 | US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme |
| 08/06/2002 | US6428988 (aav); first cre recombinase vector, second vector contains a promoter, spacer sequence flanked by loxp sites and rep/cap, and third vector containing a transgene and regulatory sequences flanked by aav inverted terminal repeats (itr) |
| 08/06/2002 | US6428986 Methods for DNA amplificating and sequencing |
| 08/06/2002 | US6428984 Cell disruption of hepatitis b surface antigen (hbsag)-expressing cells such as methylotrophic yeast cells using a high pressure homogenizer |
| 08/06/2002 | US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing |
| 08/06/2002 | US6428979 Receptor protein for human B cell stimulatory factor-2 |
| 08/06/2002 | US6428978 Producing gelatin and genuine telopeptide collagen in yeasts or other cells by coexpression of dna constructs encoding alpha1(i) and alpha2(i) collagen monomers lacking the c and/or n propeptides |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428971 Genes and proteins related to this pathway include: teichoic acid polymerase (or tap), and cdp-glycerol:poly(glycerophosphate) glycerophosphotransferase; rodc gene and proteins |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428966 Growth differentiation factor, lefty-1 |
| 08/06/2002 | US6428964 Adding to a biological sample suspected to contain a target nucleic acid, single-stranded nucleic acids that hybridize to a region of target nucleic acid if this region is unaltered, adding an agent to degrade single stranded nucleic acids |
| 08/06/2002 | US6428963 Recovering rna from a biological tissue sample wherein the sample is not an aqueous sample of a bodily fluid, comprising heating the sample in a chaotropic solution containing guanidinum compound for 5-120 minutes to a selected temp. |
| 08/06/2002 | US6428962 Nucleic acid collection barrier method and apparatus |
| 08/06/2002 | US6428961 A nucleotide sequence that encodes histidine tags in each of the three possible reading frames, and nucleic acid is less than 500 nucleotides in length. |
| 08/06/2002 | US6428960 Inserting a puromycin resistance gene, adjacent to the baculovirus gene of interest and selecting for viruses that express the selectable marker |
| 08/06/2002 | US6428959 Translocating a fluid sample through a nanopore by applying an electric field, monitoring the current amplitude, which changes with the passage of single or double stranded molecules |
| 08/06/2002 | US6428956 Drug screening; agriculture; comparing multiple targets simultaneously against combinatorial library (rna) |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428953 Retrovirus vectors; plasmids; gene delivery; genetic engineering; human immunodeficiency virus |
| 08/06/2002 | US6428951 Comprising reassembly of separate fragments of monomeric enzyme wherein reassembly of monomeric enzyme fragments is operated by interaction of molecular domains fused to each monomeric enzyme fragment |
| 08/06/2002 | US6428949 Human phosphatase inhibitor protein |
| 08/06/2002 | US6428790 Using viricidal polypeptides on solid supports for prophylaxis of human t-cell leukemia/lymphoma virus; antibodies |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428324 Vaccine |
| 08/06/2002 | CA2130832C Virus-targeted biocatalysts |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/06/2002 | CA1341381C Yeast hybrid vectors and their use for the production of polypeptides |
| 08/02/2002 | WO2001055207A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2395738A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2369477A1 In vitro assay for testing gabapentinoid activity |
| 08/01/2002 | WO2002059613A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | WO2002059612A2 Animal model and cell-line expressing modified chlorine channel |
| 08/01/2002 | WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | WO2002059607A2 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059601A1 Nucleic-acid programmable protein arrays |
| 08/01/2002 | WO2002059589A2 Multi-channel bio-separation cartridge |
| 08/01/2002 | WO2002059558A2 Means and methods for treatment evaluation |
| 08/01/2002 | WO2002059381A2 Gene for identifying individuals with familial dysautonomia |
| 08/01/2002 | WO2002059380A2 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate |
| 08/01/2002 | WO2002059378A2 Methods and compositions for identifying gene function |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059374A1 Method for identifying genes regulating desired cell phenotypes |
| 08/01/2002 | WO2002059373A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | WO2002059372A2 Three dimensional biochip |
| 08/01/2002 | WO2002059366A2 Rna polymers and uses thereof |
| 08/01/2002 | WO2002059361A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells |
| 08/01/2002 | WO2002059360A2 Ammonium sulfate for neutralization of inhibitory effects |
| 08/01/2002 | WO2002059359A2 Method for non-redundant library construction |
| 08/01/2002 | WO2002059357A2 Assay and kit for analyzing gene expression |
| 08/01/2002 | WO2002059356A2 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 08/01/2002 | WO2002059355A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | WO2002059354A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | WO2002059351A2 Accessing microbial diversity by ecological methods |
| 08/01/2002 | WO2002059350A2 Use of sialyltransferases for diagnosing and treating tumorous diseases |
| 08/01/2002 | WO2002059345A2 Nucleic acid encoding ion transporter component protein |
| 08/01/2002 | WO2002059339A1 Process for producing cytochrome c |
| 08/01/2002 | WO2002059338A2 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 08/01/2002 | WO2002059336A2 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 08/01/2002 | WO2002059335A2 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
| 08/01/2002 | WO2002059334A1 Vectors capable of imparting herbicide resistance and viral cross protection and methods |
| 08/01/2002 | WO2002059333A2 Gene promoters isolated from potato and use thereof |
| 08/01/2002 | WO2002059332A2 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 08/01/2002 | WO2002059331A1 In vivo mutation and recombination in filamentous fungi |
| 08/01/2002 | WO2002059330A2 Artificial chromosomes comprising concatemers of expressible nucleotide sequences |
| 08/01/2002 | WO2002059329A1 Novel nucleotide sequences that encode the cite gene |
| 08/01/2002 | WO2002059328A1 Human lipase and polynucleotides encoding the same |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |